CA2585353A1 - Phosphonate derivatives of mycophenolic acid - Google Patents

Phosphonate derivatives of mycophenolic acid Download PDF

Info

Publication number
CA2585353A1
CA2585353A1 CA002585353A CA2585353A CA2585353A1 CA 2585353 A1 CA2585353 A1 CA 2585353A1 CA 002585353 A CA002585353 A CA 002585353A CA 2585353 A CA2585353 A CA 2585353A CA 2585353 A1 CA2585353 A1 CA 2585353A1
Authority
CA
Canada
Prior art keywords
compound
formula
alkyl
independently
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002585353A
Other languages
English (en)
French (fr)
Inventor
William J. Watkins
Aesop Cho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2585353A1 publication Critical patent/CA2585353A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002585353A 2004-10-26 2005-10-26 Phosphonate derivatives of mycophenolic acid Abandoned CA2585353A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US62285104P 2004-10-26 2004-10-26
US62296304P 2004-10-26 2004-10-26
US62293104P 2004-10-26 2004-10-26
US62299304P 2004-10-26 2004-10-26
US62311704P 2004-10-26 2004-10-26
US62299404P 2004-10-26 2004-10-26
US62291204P 2004-10-26 2004-10-26
US60/622,993 2004-10-26
US60/622,994 2004-10-26
US60/622,851 2004-10-26
US60/623,117 2004-10-26
US60/622,931 2004-10-26
US60/622,912 2004-10-26
US60/622,963 2004-10-26
PCT/US2005/038700 WO2006047661A2 (en) 2004-10-26 2005-10-26 Phosphonate derivatives of mycophenolic acid

Publications (1)

Publication Number Publication Date
CA2585353A1 true CA2585353A1 (en) 2006-05-04

Family

ID=36228469

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002585353A Abandoned CA2585353A1 (en) 2004-10-26 2005-10-26 Phosphonate derivatives of mycophenolic acid

Country Status (6)

Country Link
US (1) US20080171724A1 (enExample)
EP (1) EP1809277A2 (enExample)
JP (1) JP2008518024A (enExample)
AU (1) AU2005299284A1 (enExample)
CA (1) CA2585353A1 (enExample)
WO (1) WO2006047661A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10369133B2 (en) 2013-07-23 2019-08-06 The University Of Tennessee Research Foundation Immunosuppressive compounds and therapeutics
LT3236972T (lt) 2014-12-26 2021-11-10 Emory University Antivirusiniai n4-hidroksicitidino dariniai
US10450335B2 (en) 2015-12-15 2019-10-22 Merck Sharp & Dohme Corp. Antiviral oxime phosphoramide compounds
WO2018080903A1 (en) 2016-10-26 2018-05-03 Merck Sharp & Dohme Corp. Antiviral aryl-amide phosphodiamide compounds
AU2017378893A1 (en) 2016-12-22 2019-05-16 Idenix Pharmaceuticals Llc Antiviral benzyl-amine phosphodiamide compounds
LT3706762T (lt) 2017-12-07 2024-12-27 Emory University N4-hidroksicitidinas ir jo dariniai bei susiję naudojimo prieš virusus būdai
EP3823629B1 (en) 2018-07-19 2024-12-25 Merck Sharp & Dohme LLC Phosphinic amide prodrugs of tenofovir

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US5446137B1 (en) * 1993-12-09 1998-10-06 Behringwerke Ag Oligonucleotides containing 4'-substituted nucleotides
US5493030A (en) * 1994-02-18 1996-02-20 Syntex (U.S.A.) Inc. 5-substituted derivatives of mycophenolic acid
US5747498A (en) * 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
US5874577A (en) * 1996-04-03 1999-02-23 Medichem Research, Inc. Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof
US6174888B1 (en) * 1998-05-28 2001-01-16 Novartis Ag 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones
US6395763B1 (en) * 1999-06-25 2002-05-28 Vertex Pharmaceuticals Incorporated Prodrugs of carbamate inhibitors of IMPDH
AU2001234174A1 (en) * 2000-02-29 2001-09-12 Mitsubishi Pharma Corporation Phosphonate nucleotide compound

Also Published As

Publication number Publication date
JP2008518024A (ja) 2008-05-29
US20080171724A1 (en) 2008-07-17
WO2006047661A3 (en) 2006-08-24
WO2006047661A2 (en) 2006-05-04
AU2005299284A1 (en) 2006-05-04
EP1809277A2 (en) 2007-07-25

Similar Documents

Publication Publication Date Title
CA2574121C (en) Antiviral compounds
US7642339B2 (en) Antiviral compounds
CA2523083C (en) Antiviral phosphonate analogs
US7470724B2 (en) Phosphonate compounds having immuno-modulatory activity
US20070072809A1 (en) Antiviral compounds
CA2614674A1 (en) Antiviral compounds
AU2004308974A1 (en) Kinase inhibitor phosphonate conjugates
US20070027116A1 (en) Therapeutic phosphonate derivatives
US7427636B2 (en) Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
US20090156558A1 (en) Phosphonate analogs of antimetabolites
AU2006272521A1 (en) Antiviral phosphonate conjugates for inhibition of HIV
US7427624B2 (en) Purine nucleoside phosphorylase inhibitory phosphonate compounds
CA2585353A1 (en) Phosphonate derivatives of mycophenolic acid
AU2011218664B2 (en) Antiviral compounds
CA2585281A1 (en) Phosphonate substituted kinase inhibitors

Legal Events

Date Code Title Description
FZDE Discontinued